.png)
Molecular Devices Company, California, United States
Shan Dhamija is the Vice President of Strategy and Innovation at Molecular Devices, A Danaher Company, where he leads strategic planning and inorganic growth initiatives. He started his career in pharmaceutical R&D at Pfizer, progressively taking on roles with increasing complexity across strategy, commercial execution, and operational excellence at Deloitte Consulting and Leica Biosystems. He earned his MBA and graduate degrees in Electrical and Biomedical Engineering from the University of Michigan, Ann Arbor, and his bachelor’s degree in electrical engineering from Delhi University, India.
Disclosure information not submitted.
Automated cell culture system launched to fast-track drug discoveries
Monday, February 5, 2024
4:30 PM – 4:50 PM EST